Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Carcinoma
Cholangiocarcinoma
Bile Duct Cancer

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Zimberelimab
DRUG: Quemliclustat

Sponsor

Nataliya Uboha

Collaborators

[object Object]
[object Object]
[object Object]